Raymond James Trust N.A. lessened its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 5.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 5,135 shares of the medical instruments supplier’s stock after selling 270 shares during the quarter. Raymond James Trust N.A.’s holdings in DENTSPLY SIRONA were worth $300,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also made changes to their positions in the company. Parametric Portfolio Associates LLC boosted its stake in DENTSPLY SIRONA by 3.1% during the 1st quarter. Parametric Portfolio Associates LLC now owns 992,095 shares of the medical instruments supplier’s stock worth $49,198,000 after purchasing an additional 29,541 shares during the last quarter. S&CO Inc. boosted its stake in DENTSPLY SIRONA by 4.3% during the 1st quarter. S&CO Inc. now owns 57,040 shares of the medical instruments supplier’s stock worth $2,829,000 after purchasing an additional 2,352 shares during the last quarter. Chartwell Investment Partners LLC acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth $328,000. Mercer Global Advisors Inc. ADV acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth $317,000. Finally, Cleararc Capital Inc. acquired a new stake in DENTSPLY SIRONA during the 1st quarter worth $268,000. 91.93% of the stock is currently owned by institutional investors.
Shares of NASDAQ XRAY traded down $1.48 during trading on Wednesday, hitting $55.19. 89,242 shares of the company were exchanged, compared to its average volume of 1,160,627. DENTSPLY SIRONA Inc has a 12-month low of $33.93 and a 12-month high of $59.40. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.06 and a quick ratio of 1.35. The company’s fifty day moving average is $57.22. The stock has a market cap of $13.11 billion, a price-to-earnings ratio of 27.44, a PEG ratio of 2.08 and a beta of 0.98.
The business also recently disclosed a quarterly dividend, which was paid on Friday, July 12th. Investors of record on Friday, June 28th were issued a $0.0875 dividend. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.09. This represents a $0.35 annualized dividend and a yield of 0.63%. The ex-dividend date was Thursday, June 27th. DENTSPLY SIRONA’s payout ratio is 17.41%.
Several equities research analysts have issued reports on XRAY shares. HC Wainwright reaffirmed a “neutral” rating and set a $57.00 target price (up previously from $55.00) on shares of DENTSPLY SIRONA in a research note on Tuesday, July 9th. Zacks Investment Research upgraded GALP ENERGIA SG/ADR from a “sell” rating to a “hold” rating in a report on Monday, May 27th. ValuEngine upgraded ZIX from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 4th. Guggenheim started coverage on Patterson Companies in a report on Wednesday, April 17th. They set a “neutral” rating and a $23.00 price target on the stock. Finally, Evercore ISI set a $150.00 price target on Proofpoint and gave the stock a “buy” rating in a report on Friday, July 26th. Ten investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $53.77.
In other DENTSPLY SIRONA news, Director Eric Brandt sold 9,160 shares of the business’s stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $53.45, for a total transaction of $489,602.00. Following the sale, the director now directly owns 26,003 shares in the company, valued at $1,389,860.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Betsy D. Holden purchased 2,720 shares of the business’s stock in a transaction on Thursday, June 6th. The shares were acquired at an average price of $55.31 per share, for a total transaction of $150,443.20. Following the completion of the purchase, the director now directly owns 9,224 shares of the company’s stock, valued at $510,179.44. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 26,417 shares of company stock worth $1,425,395 and sold 138,922 shares worth $7,631,805. 0.62% of the stock is currently owned by insiders.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.